Avirulent mutants of rabies virus and their use as live vaccine
- 1 November 1993
- journal article
- editorial
- Published by Elsevier in Trends in Microbiology
- Vol. 1 (8) , 317-320
- https://doi.org/10.1016/0966-842x(93)90010-o
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Oral rabies vaccination of arctic foxes (Alopex lagopus) with an attenuated vaccineVaccine, 1992
- Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculationVirology, 1991
- Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult miceVirology, 1989
- Oral Immunization of Wildlife Against Rabies: Concept and First Field ExperimentsClinical Infectious Diseases, 1988
- Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brainJournal of Virology, 1985
- Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoproteinJournal of Virology, 1985
- Amino Acid Sequence Similarity Between Rabies Virus Glycoprotein and Snake Venom Curaremimetic NeurotoxinsScience, 1984
- Molecular Basis of Rabies Virus Virulence. I. Selection of Avirulent Mutants of the CVS Strain with Anti-G Monoclonal AntibodiesJournal of General Virology, 1982
- Rapid Evolution of RNA GenomesScience, 1982
- THE USE OF COMMERCIALLY AVAILABLE VACCINES FOR THE ORAL VACCINATION OF FOXES AGAINST RABIESAmerican Journal of Epidemiology, 1972